Table 1.
Characteristics of patients before LTx and healthy controls.
| Characteristics | Post-LTx Patients | HCs (n = 12) | p | |
|---|---|---|---|---|
| Infection after LTx (n = 9) | No Infection after LTx (n = 10) | |||
| Age (years), mean ± SD | 50.89 ± 10.89 | 44.90 ± 9.54 | 46.12 ± 10.92 | 0.33 |
| Gender, n | 0.78 | |||
| Female | 2 | 2 | 4 | |
| Male | 7 | 8 | 8 | |
| Primary liver disease, n | 0.94 | |||
| Hepatitis B | 5 | 9 | NA | |
| Hepatitis C | 2 | 1 | NA | |
| HCC | 4 | 5 | NA | |
| MELD scores, median (IQR) | 27.00 (26.00, 28.50) | 27.00 (24.50, 31.50) | NA | 0.97 |
| Cyclosporine A, median (IQR) | 525.0 (371.6, 617.1) | 539.5 (328.7, 713.7) | NA | 0.43 |
LTx: Liver transplantation; HCs: healthy controls; IQR: interquartile range; HCC: Hepatocellular carcinoma; MELD: Mayo End-Stage Liver Disease. The p-value of age and gender were generated from the two patient groups and the heathy control group using one-way ANOVA. The p-value regarding the primary liver disease, MELD scores, and concentration of Cyclosporine A postdose levels (C-2) were calculated from the two patient groups using the Mann–Whitney test.